CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Revenue:
Total revenue	$ 216,485	$ 211,789
Operating costs and expenses:
Payroll	41,439	34,860
Contract services	60,532	38,655
Medical supplies	4,009	3,801
Depreciation and amortization	5,492	5,092
Other	13,283	11,043
Total operating costs and expenses	124,755	93,451
Gross profit	91,730	118,338
Corporate and other costs:
Stock-based compensation	(3,915)	27,642
General and administrative expenses	14,380	10,035
Total corporate and other costs	10,465	37,677
Operating income	81,265	80,661
Interest expense, net	4,682	6,120
Other expense	23	3,325
Income before taxes	76,560	71,216
Income tax expense	13,797	20,410
Net income	62,763	50,806
Less: net income attributable to noncontrolling interests	15,956	29,589
Net income attributable to Nutex Health Inc.	$ 46,807	$ 21,217
Earnings per common share:
Basic earnings (loss) per common share (in dollars per share)	$ 6.70	$ 3.74
Diluted earnings (loss) per common share (in dollars per share)	$ 6.52	$ 3.33
Hospital division
Revenue:
Total revenue	$ 207,570	$ 203,947
Population health management division
Revenue:
Total revenue	$ 8,915	$ 7,842